Juan P. Sade

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium.

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium.

Journal: Clinical genitourinary cancer

Published: January 15, 2026

Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study.

Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 10, 2025

Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study.

Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study.

Journal: Urologic oncology

Published: December 09, 2025

Treatment Trends in Metastatic Renal Clear Cell Carcinoma in Argentina.

Treatment Trends in Metastatic Renal Clear Cell Carcinoma in Argentina.

Journal: JCO global oncology

Published: April 23, 2025

The (Re) evolution in the Treatment of Bladder Cancer.

The (Re) evolution in the Treatment of Bladder Cancer.

Journal: Urology

Published: February 10, 2025

Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary.

Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary.

Journal: Future oncology (London, England)

Published: January 16, 2025

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial.

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial.

Journal: European urology

Published: November 19, 2024

Genomic Landscape in Prostate Cancer in a Latin American Population.

Genomic Landscape in Prostate Cancer in a Latin American Population.

Journal: JCO global oncology

Published: September 30, 2024

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).

Journal: European urology

Published: September 01, 2024

Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab.

Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab.

Journal: Scientific reports

Published: July 22, 2024

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Journal: Cancer immunology, immunotherapy : CII

Published: February 05, 2024

The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population.

The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population.

Journal: Clinical genitourinary cancer

Published: January 29, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026